Thus, taking control of excessive IL-23p19 expression may be one of the essential factors responsible for novel therapies for IBD and the bacterial compounds and the type of pattern recognition receptor that involved in the inducible expression of IL-23p19 in the intestine deserve fuller exploration. The gene discussed is IL23A; the disease is inflammatory bowel disease.